MeiraGTx Holdings plc Notes Payable, Current
MeiraGTx Holdings plc (MGTX) had Notes Payable, Current of $24.87 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-13
- 2026-03-31: Notes Payable, Current $24.87M.
- 2025-12-31: Notes Payable, Current $24.65M.
- 2025-09-30: Notes Payable, Current $74.06M.
- 2017-12-31: Notes Payable, Current $1.44M.
| Period end | Notes Payable, Current |
|---|---|
| 2026-03-31 | $24.87M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $24.65M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $74.06M 10-Q · filed 2025-11-13 |
| 2017-12-31 | $1.44M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |